Ownership history in MARSHALL WACE, LLP · 9 quarters on record
This page tracks every 13F SEC filing in which MARSHALL WACE, LLP reported a position in CELLECTIS - ADR (CLLS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 178,473 | +168,038 | +1610.3% | 0.00% | $864K | $4.84 |
| 2025 Q3 | REDUCED | 10,435 | -98,309 | -90.4% | 0.00% | $30K | $2.85 |
| 2022 Q3 | REDUCED | 108,744 | -5,697 | -5.0% | 0.00% | $249K | $2.29 |
| 2022 Q2 | REDUCED | 114,441 | -31,757 | -21.7% | 0.00% | $324K | $2.83 |
| 2022 Q1 | ADDED | 146,198 | +140,714 | +2565.9% | 0.00% | $663K | $4.54 |
| 2021 Q4 | REDUCED | 5,484 | -32,988 | -85.7% | 0.00% | $44K | $8.12 |
| 2020 Q2 | ADDED | 38,472 | +22,229 | +136.9% | 0.00% | $685K | $17.80 |
| 2019 Q3 | REDUCED | 16,243 | -33,241 | -67.2% | 0.00% | $169K | $10.40 |
| 2019 Q2 | INITIATED | 49,484 | — | — | 0.01% | $772K | — |
As of 2025 Q4 — sorted by position size